Skip to content
Screener

Beta Bionics BBNX Income Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
$32.01M+37.8%$27.63M+56.6%$32.12M+57.1%$27.25M+63.1%$23.24M+54.4%
$13.11M+22.1%$11.19M+29.1%$13.18M+50.6%$12.13M+55.7%$10.74M+54.2%
$18.9M+51.2%$16.44M+83.2%$18.94M+62.1%$15.12M+69.6%$12.5M+54.7%
59%+5.2pp59.5%+8.6pp59%+1.8pp55.5%+2.1pp53.8%+0.1pp
$10.24M+15.4%$10.36M+36.4%$10.13M+10.0%$8.2M+59.4%$8.87M+39.7%
$24.64M+57.7%$20.74M+54.7%$16.33M+51.2%$16.05M+66.4%$15.62M+74.1%
$9.6M+21.8%$9.62M+45.2%$8.6M+82.7%$7.92M+55.2%$7.88M+73.4%
$44.48M+37.4%$40.71M+47.4%$35.07M+41.8%$32.16M+61.7%$32.38M+63.0%
-$25.58M-28.7%-$24.27M-30.2%-$16.12M-23.7%-$17.04M-55.3%-$19.87M-68.6%
-79.9%+5.6pp-87.9%+17.8pp-50.2%+13.6pp-62.5%+3.2pp-85.5%-7.2pp
$2.18M-27.6%$2.38M+124%$2.83M+128%$3M+212%
-$23.4M-38.7%-$21.9M+23.6%-$13.47M+25.6%-$14.21M-45.9%-$16.87M-16.6%
-73.1%-0.5pp-79.3%+83.2pp-41.9%+46.7pp-52.1%+6.1pp-72.6%+23.5pp
-$0.53-35.9%-$0.49+47.3%-$0.29+89.4%-$0.33+77.4%-$0.39+83.5%
-$24.87M-27.4%-$23.69M-29.2%-$15.59M-21.7%-$16.66M-56.5%-$19.53M-70.0%
-77.7%+6.3pp-85.7%+18.2pp-48.5%+14.1pp-61.1%+2.6pp-84%-7.7pp
-$25.58M-28.7%-$24.27M-30.2%-$16.12M-23.7%-$17.04M-55.3%-$19.87M-68.6%

FAQ

What is Beta Bionics's revenue?
Beta Bionics (BBNX) generated $119.0M in revenue over the trailing twelve months, up 52.5% year over year.
Is Beta Bionics profitable?
Beta Bionics is not currently profitable: it reported a net loss of $73.0M over the trailing twelve months, a -61.3% net margin.
What are Beta Bionics's profit margins?
Gross margin is 58.3% and operating margin is -69.8%, with a -61.3% net margin.
What is Beta Bionics's earnings per share?
Beta Bionics's diluted EPS over the trailing twelve months is $-1.64.
Where does Beta Bionics's income statement data come from?
Every line is extracted from Beta Bionics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.